What is BioMarin Pharmaceuticals Inc's Market Cap?

BioMarin Pharmaceuticals Inc's Market Cap is $12.5B, based on as-reported figures from SEC (XBRL) filings.

What is BioMarin Pharmaceuticals Inc's Enterprise Value?

BioMarin Pharmaceuticals Inc's Enterprise Value is $15.8B, based on as-reported figures from SEC (XBRL) filings.

What is BioMarin Pharmaceuticals Inc's Trailing P/E?

BioMarin Pharmaceuticals Inc's Trailing P/E is 170.9×, based on as-reported figures from SEC (XBRL) filings.

What is BioMarin Pharmaceuticals Inc's Price / Sales?

BioMarin Pharmaceuticals Inc's Price / Sales is 3.7×, based on as-reported figures from SEC (XBRL) filings.

What is BioMarin Pharmaceuticals Inc's EV / Revenue?

BioMarin Pharmaceuticals Inc's EV / Revenue is 4.6×, based on as-reported figures from SEC (XBRL) filings.

What is BioMarin Pharmaceuticals Inc's EV / EBITDA?

BioMarin Pharmaceuticals Inc's EV / EBITDA is 52.4×, based on as-reported figures from SEC (XBRL) filings.

What is BioMarin Pharmaceuticals Inc's Revenue (TTM)?

BioMarin Pharmaceuticals Inc's Revenue (TTM) is $3.4B, based on as-reported figures from SEC (XBRL) filings.

What is BioMarin Pharmaceuticals Inc's Net Income (TTM)?

BioMarin Pharmaceuticals Inc's Net Income (TTM) is $73.0M, based on as-reported figures from SEC (XBRL) filings.

What is BioMarin Pharmaceuticals Inc's EBITDA?

BioMarin Pharmaceuticals Inc's EBITDA is $302.2M, based on as-reported figures from SEC (XBRL) filings.

What is BioMarin Pharmaceuticals Inc's Diluted EPS (TTM)?

BioMarin Pharmaceuticals Inc's Diluted EPS (TTM) is 0.38, based on as-reported figures from SEC (XBRL) filings.

BioMarin Pharmaceuticals Inc (BMRN) Financial Statements

BioMarin Pharmaceuticals Inc

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S76R05

XNAS · usd

64.41▼ 0.22 (-0.34%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close64.63

Day's Range63.64 – 65.33

52-Week Range49.26 – 70.98

Volume1.9M

Avg Volume2.1M

Share Statistics

Shares Outstanding

Employees3,221

ExchangeXNAS

Listed1999-07-23

Share count as of July 28, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about BioMarin Pharmaceuticals Inc (BMRN)

What is BioMarin Pharmaceuticals Inc's Market Cap?: BioMarin Pharmaceuticals Inc's Market Cap is $12.5B, based on as-reported figures from SEC (XBRL) filings.
What is BioMarin Pharmaceuticals Inc's Enterprise Value?: BioMarin Pharmaceuticals Inc's Enterprise Value is $15.8B, based on as-reported figures from SEC (XBRL) filings.
What is BioMarin Pharmaceuticals Inc's Trailing P/E?: BioMarin Pharmaceuticals Inc's Trailing P/E is 170.9×, based on as-reported figures from SEC (XBRL) filings.
What is BioMarin Pharmaceuticals Inc's Price / Sales?: BioMarin Pharmaceuticals Inc's Price / Sales is 3.7×, based on as-reported figures from SEC (XBRL) filings.
What is BioMarin Pharmaceuticals Inc's EV / Revenue?: BioMarin Pharmaceuticals Inc's EV / Revenue is 4.6×, based on as-reported figures from SEC (XBRL) filings.
What is BioMarin Pharmaceuticals Inc's EV / EBITDA?: BioMarin Pharmaceuticals Inc's EV / EBITDA is 52.4×, based on as-reported figures from SEC (XBRL) filings.
What is BioMarin Pharmaceuticals Inc's Revenue (TTM)?: BioMarin Pharmaceuticals Inc's Revenue (TTM) is $3.4B, based on as-reported figures from SEC (XBRL) filings.
What is BioMarin Pharmaceuticals Inc's Net Income (TTM)?: BioMarin Pharmaceuticals Inc's Net Income (TTM) is $73.0M, based on as-reported figures from SEC (XBRL) filings.
What is BioMarin Pharmaceuticals Inc's EBITDA?: BioMarin Pharmaceuticals Inc's EBITDA is $302.2M, based on as-reported figures from SEC (XBRL) filings.
What is BioMarin Pharmaceuticals Inc's Diluted EPS (TTM)?: BioMarin Pharmaceuticals Inc's Diluted EPS (TTM) is 0.38, based on as-reported figures from SEC (XBRL) filings.